Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis
about
Cancer pharmacogenomics: strategies and challengesStatistical analysis of big data on pharmacogenomicsPharmacogenomics in early-phase clinical developmentThe success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era.Identification of ITGA2B and ITGB3 Single-Nucleotide Polymorphisms and Their Influences on the Platelet FunctionConcept of pharmacogenomics and future considerations.
P2860
Statistical Optimization of Pharmacogenomics Association Studies: Key Considerations from Study Design to Analysis
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Statistical Optimization of Ph ...... from Study Design to Analysis
@ast
Statistical Optimization of Ph ...... from Study Design to Analysis
@en
type
label
Statistical Optimization of Ph ...... from Study Design to Analysis
@ast
Statistical Optimization of Ph ...... from Study Design to Analysis
@en
prefLabel
Statistical Optimization of Ph ...... from Study Design to Analysis
@ast
Statistical Optimization of Ph ...... from Study Design to Analysis
@en
P2860
P1476
Statistical Optimization of Ph ...... from Study Design to Analysis
@en
P2093
Benjamin J Grady
P2860
P356
10.2174/187569211794728805
P577
2011-03-01T00:00:00Z